Aspen Pharmacare Holdings Performance
APNHFDelisted Stock | USD 12.25 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Aspen Pharmacare are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Aspen Pharmacare Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Aspen Pharmacare is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow | 6 B | |
Total Cashflows From Investing Activities | -2.2 B |
Aspen |
Aspen Pharmacare Relative Risk vs. Return Landscape
If you would invest 1,225 in Aspen Pharmacare Holdings on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Aspen Pharmacare Holdings or generate 0.0% return on investment over 90 days. Aspen Pharmacare Holdings is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Aspen, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Aspen Pharmacare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aspen Pharmacare's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Aspen Pharmacare Holdings, and traders can use it to determine the average amount a Aspen Pharmacare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
APNHF |
Based on monthly moving average Aspen Pharmacare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aspen Pharmacare by adding Aspen Pharmacare to a well-diversified portfolio.
Aspen Pharmacare Fundamentals Growth
Aspen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Aspen Pharmacare, and Aspen Pharmacare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aspen Pink Sheet performance.
Return On Equity | 0.095 | |||
Return On Asset | 0.0499 | |||
Profit Margin | 0.17 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 4.58 B | |||
Shares Outstanding | 444.95 M | |||
Price To Earning | 11.83 X | |||
Price To Book | 0.98 X | |||
Price To Sales | 0.10 X | |||
Revenue | 38.61 B | |||
EBITDA | 10.61 B | |||
Cash And Equivalents | 7.88 B | |||
Cash Per Share | 17.25 X | |||
Total Debt | 105 M | |||
Debt To Equity | 0.38 % | |||
Book Value Per Share | 159.44 X | |||
Cash Flow From Operations | 5.37 B | |||
Earnings Per Share | 0.80 X | |||
Total Asset | 111.38 B | |||
Retained Earnings | 28.4 B | |||
Current Asset | 37.2 B | |||
Current Liabilities | 21.1 B | |||
About Aspen Pharmacare Performance
By analyzing Aspen Pharmacare's fundamental ratios, stakeholders can gain valuable insights into Aspen Pharmacare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aspen Pharmacare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aspen Pharmacare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. The company was founded in 1850 and is headquartered in Durban, South Africa. Aspen Pharmacare is traded on OTC Exchange in the United States.Things to note about Aspen Pharmacare Holdings performance evaluation
Checking the ongoing alerts about Aspen Pharmacare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Aspen Pharmacare Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Aspen Pharmacare is not yet fully synchronised with the market data | |
Aspen Pharmacare generated a negative expected return over the last 90 days | |
Aspen Pharmacare has a very high chance of going through financial distress in the upcoming years | |
About 61.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from MacroaxisInsider: Acquisition by Riley Antony A of 22514 shares of Forte Biosciences at 5.552 subject to Rule 16b-3 |
- Analyzing Aspen Pharmacare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aspen Pharmacare's stock is overvalued or undervalued compared to its peers.
- Examining Aspen Pharmacare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aspen Pharmacare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aspen Pharmacare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aspen Pharmacare's pink sheet. These opinions can provide insight into Aspen Pharmacare's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Aspen Pink Sheet
If you are still planning to invest in Aspen Pharmacare Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aspen Pharmacare's history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
CEOs Directory Screen CEOs from public companies around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Global Correlations Find global opportunities by holding instruments from different markets |